Tissue Engineered Skin Substitutes Market Size, Share & Trends Report

Tissue Engineered Skin Substitutes Market Size, Share & Trends Analysis Report By Product (Synthetic, Biosynthetic, Biological), By Application (Acute Wounds, Chronic Wounds), By End Use, By Region, And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68038-500-7
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
                 1.1 Research Methodology
                     1.1.1 Information procurement
                 1.2 Information or Data Analysis
                 1.3 Market Formulation & Validation
                     1.3.1 Market: CAGR Calculation
                 1.4 Segment Share Calculation
                 1.5 List of Secondary Sources
Chapter 2 Executive Summary
                 2.1 Market Outlook
                 2.2 Segment Outlook
                     2.2.1 Market Segmentation
                 2.3 Competitive Insights
                 2.4 Market Snapshot
Chapter 3 Tissue Engineered Skin Substitutes Market Variables, Trends & Scope
                 3.1 Market Lineage Outlook
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 Product Pipeline Analysis
                 3.4 Regulatory Framework
                 3.5 Market Dynamics
                     3.5.1 Market driver analysis
                          3.5.1.1 High demand for skin grafts
                          3.5.1.2 Rising prevalence of acute and chronic wounds
                          3.5.1.3 Technological advancements
                     3.5.2 Market restraint analysis
                          3.5.2.1 High treatment cost
                          3.5.2.2 Stringent regulations
                 3.6 Tissue Engineered Skin Substitutes Market Analysis Tools
                     3.6.1 SWOT Analysis, by PEST
                     3.6.2 Porter’s five forces analysis
Chapter 4 Tissue Engineered Skin Substitutes Market: Segment Analysis, By Product, 2016 - 2027 (USD Million)
                 4.1 Definitions & Scope
                 4.2 Product Market Share Analysis, 2019 & 2027
                 4.3 Segment Dashboard
                 4.4 Tissue Engineered Skin Substitutes Market, by Product, 2016 to 2027
                 4.5 Market Size Forecasts and Trend Analysis
                     4.5.1 Biological
                          4.5.1.1 Biological market, 2016 - 2027 (USD Million)
                     4.5.2 Biosynthetic
                          4.5.2.1 Biosynthetic market, 2016 - 2027 (USD Million)
                     4.5.2 Synthetic
                          4.5.2.1 Synthetic market, 2016 - 2027 (USD Million)
Chapter 5 Tissue Engineered Skin Substitutes Market: Segment Analysis, By Application, 2016 - 2027 (USD Million)
                 5.1 Definitions & Scope
                 5.2 Application Market Share Analysis, 2019 & 2027
                 5.3 Segment Dashboard
                 5.4 Tissue Engineered Skin Substitutes Market, by Application, 2016 to 2027
                 5.5 Market Size Forecasts & Trend Analysis
                     5.5.1 Acute wounds
                          5.5.1.1 Acute wounds market, 2016 - 2027 (USD Million)
                          5.5.1.2 Surgery & trauma wounds
                               5.5.1.2.1 Surgery & trauma wounds market, 2016 - 2027 (USD Million)
                          5.5.1.3 Burn injuries
                               5.5.1.3.1 Burn injuries market, 2016 - 2027 (USD Million)
                     5.5.2 Chronic wounds
                          5.5.2.1 Chronic wounds market, 2016 - 2027 (USD Million)
                          5.5.2.2 Diabetic foot ulcers
                               5.5.2.2.1 Diabetic foot ulcers market, 2016 - 2027 (USD Million)
                          5.5.2.3 Venous leg ulcers
                               5.5.2.3.1 Venous leg ulcers market, 2016 - 2027 (USD Million)
                          5.5.2.4 Pressure ulcers
                               5.5.2.4.1 Pressure ulcers market, 2016 - 2027 (USD Million)
                          5.5.2.5 Other chronic wounds
                               5.5.2.5.1 Other chronic wounds market, 2016 - 2027 (USD Million)
Chapter 6 Tissue Engineered Skin Substitutes Market: Segment Analysis, By End Use, 2016 - 2027 (USD Million)
                 6.1 Definitions & Scope
                 6.2 End Use Market Share Analysis, 2019 & 2027
                 6.3 Segment Dashboard
                 6.4 Tissue Engineered Skin Substitutes Market, by End Use, 2016 to 2027
                 6.5 Market Size Forecasts & Trend Analysis
                     6.5.1 Hospitals
                          6.5.1.1 Hospitals market, 2016 - 2027 (USD Million)
                     6.5.2 Wound care centers
                          6.5.2.1 Wound care centers market, 2016 - 2027 (USD Million)
                     6.5.2 Others
                          6.5.2.1 Others market, 2016 - 2027 (USD Million)
Chapter 7 Tissue Engineered Skin Substitutes Market: Regional Market Analysis, By Product, Application, and End Use, 2016 - 2027 (USD Million)
                 7.1 Definitions & Scope
                 7.2 Regional Market Share Analysis, 2019 & 2027
                 7.3 Regional Market Snapshot
                 7.4 Market Size Forecasts & Trend Analysis
                     7.4.1 North America
                          7.4.1.1 North America tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.1.2 U.S.
                               7.4.1.2.1 U.S. tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.1.3 Canada
                               7.4.1.3.1 Canada tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                     7.4.2 Europe
                          7.4.2.1 Europe tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.2.2 U.K.
                               7.4.2.2.1 U.K. tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.2.3 Germany
                               7.4.2.3.1 Germany tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                     7.4.3 Asia Pacific
                          7.4.3.1 Asia Pacific tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.3.2 Japan
                               7.4.3.2.1 Japan tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.3.3 China
                               7.4.3.3.1 China tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                     7.4.4 Latin America
                          7.4.4.1 Latin America tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.4.2 Brazil
                               7.4.4.2.1 Brazil tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.4.3 Mexico
                               7.4.4.3.1 Mexico tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                     7.4.5 Middle East & Africa
                          7.4.5.1 Middle East & Africa tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.5.2 South Africa
                               7.4.5.2.1 South Africa tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
                          7.4.5.3 Saudi Arabia
                               7.4.5.3.1 Saudi Arabia tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Chapter 8 Tissue Engineered Skin Substitutes Market: Competitive Analysis
                 8.1 Recent Development & Impact Analysis, by Key Market Participants
                 8.2 Company Profiles
                     8.2.1 Amarantus BioScience Holdings
                          8.2.1.1 Company overview
                          8.2.1.2 Financial performance
                          8.2.1.3 Product benchmarking
                          8.2.1.4 Strategic initiatives
                     8.2.2 Organogenesis, Inc.
                          8.2.2.1 Company overview
                          8.2.2.2 Financial performance
                          8.2.2.3 Product benchmarking
                          8.2.2.4 Strategic initiatives
                     8.2.3 KCI Licensing, Inc.
                          8.2.3.1 Company overview
                          8.2.3.2 Financial performance
                          8.2.3.3 Product benchmarking
                          8.2.3.4 Strategic initiatives
                     8.2.4 Smith & Nephew
                          8.2.4.1 Company overview
                          8.2.4.2 Financial performance
                          8.2.4.3 Product benchmarking
                          8.2.4.4 Strategic initiatives
                     8.2.5 BSN medical
                          8.2.5.1 Company overview
                          8.2.5.2 Financial performance
                          8.2.5.3 Product benchmarking
                          8.2.5.4 Strategic initiatives
                     8.2.6 Mölnlycke Health Care AB
                          8.2.6.1 Company overview
                          8.2.6.2 Financial performance
                          8.2.6.3 Product benchmarking
                          8.2.6.4 Strategic initiatives
                     8.2.7 Integra LifeSciences Corporation
                          8.2.7.1 Company overview
                          8.2.7.2 Financial performance
                          8.2.7.3 Product benchmarking
                          8.2.7.4 Strategic initiatives
                     8.2.8 Medtronic
                          8.2.8.1 Company overview
                          8.2.8.2 Financial performance
                          8.2.8.3 Product benchmarking
                          8.2.8.4 Strategic initiatives
                     8.2.9 Tissue Regenix
                          8.2.9.1 Company overview
                          8.2.9.2 Financial performance
                          8.2.9.3 Product benchmarking
                          8.2.9.4 Strategic initiatives


List of Tables

Table 1. List of secondary sources
Table 2. Global tissue engineered skin substitutes market, by region, 2016 - 2027 (USD Million)
Table 3. Global tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 4. Global tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 5. Global tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 6. North America tissue engineered skin substitutes market, by country, 2016 - 2027 (USD Million)
Table 7. North America tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 8. North America tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 9. North America tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 10. U.S. tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 11. U.S. tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 12. U.S. tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 13. Canada tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 14. Canada tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 15. Canada tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 16. Europe tissue engineered skin substitutes market, by country, 2016 - 2027 (USD Million)
Table 17. Europe tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 18. Europe tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 19. Europe tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 20. U.K. tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 21. U.K. tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 22. U.K. tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 23. Germany tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 24. Germany tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 25. Germany tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 26. Asia Pacific tissue engineered skin substitutes market, by country, 2016 - 2027 (USD Million)
Table 27. Asia Pacific tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 28. Asia Pacific tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 29. Asia Pacific tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 30. Japan tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 31. Japan tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 32. Japan tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 33. China tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 34. China tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 35. China tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 36. Latin America tissue engineered skin substitutes market, by country, 2016 - 2027 (USD Million)
Table 37. Latin America tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 38. Latin America tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 39. Latin America tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 40. Brazil tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 41. Brazil tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 42. Brazil tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 43. Mexico tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 44. Mexico tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 45. Mexico tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 46. Middle East & Africa tissue engineered skin substitutes market, by country, 2016 - 2027 (USD Million)
Table 47. Middle East & Africa tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 48. Middle East & Africa tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 49. Middle East & Africa tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 50. South Africa tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 51. South Africa tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 52. South Africa tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)
Table 53. Saudi Arabia tissue engineered skin substitutes market, by product, 2016 - 2027 (USD Million)
Table 54. Saudi Arabia tissue engineered skin substitutes market, by application, 2016 - 2027 (USD Million)
Table 55. Saudi Arabia tissue engineered skin substitutes market, by end use, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Disinfection caps market segmentation
Fig. 9 Market summary
Fig. 10 Market lineage outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Reimbursement pathway
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Porter’s five forces analysis
Fig. 17 Tissue engineered skin substitutes market: Product movement analysis
Fig. 18 Tissue engineered skin substitutes market: Product scope & market share
Fig. 19 Tissue engineered skin substitutes market product outlook: Key takeaways
Fig. 20 Biological tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 21 Biosynthetic tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 22 Synthetic tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 23 Tissue engineered skin substitutes market: Application movement analysis
Fig. 24 Tissue engineered skin substitutes market: Application scope & market share
Fig. 25 Tissue engineered skin substitutes market application outlook: Key takeaways
Fig. 26 Acute wounds market, 2016 - 2027 (USD Million)
Fig. 27 Surgery & trauma wounds market, 2016 - 2027 (USD Million)
Fig. 28 Burn injury wounds market, 2016 - 2027 (USD Million)
Fig. 29 Chronic wounds market, 2016 - 2027 (USD Million)
Fig. 30 Diabetic foot ulcers market, 2016 - 2027 (USD Million)
Fig. 31 Venous leg ulcers market, 2016 - 2027 (USD Million)
Fig. 32 Pressure ulcers market, 2016 - 2027 (USD Million)
Fig. 33 Other chronic wounds market, 2016 - 2027 (USD Million)
Fig. 34 Tissue engineered skin substitutes market: End use movement analysis
Fig. 35 Tissue engineered skin substitutes market: End use scope & market share
Fig. 36 Tissue engineered skin substitutes market end use outlook: Key takeaways
Fig. 37 Hospitals market, 2016 - 2027 (USD Million)
Fig. 38 Wound care centers market, 2016 - 2027 (USD Million)
Fig. 39 Others market, 2016 - 2027 (USD Million)
Fig. 40 Regional Outlook, 2019 & 2027
Fig. 41 Regional market place: Key takeaways
Fig. 42 North America tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 43 U.S tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 44 Canada tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 45 Europe tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 46 U.K. tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 47 Germany tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 48 Asia Pacific tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 49 Japan tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 50 China tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 51 Latin America tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 52 Brazil tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 53 Mexico tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 54 Middle East & Africa tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 55 South Africa tissue engineered skin substitutes market, 2016 - 2027 (USD Million)
Fig. 56 Saudi Arabia tissue engineered skin substitutes market, 2016 - 2027 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.